Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hancock

Showing results (331-340 of 1,168) with videos related to

Pageof 117
Sort By:
Thrombosis and Haemostasis|June 30, 1978
The effects of an increase in endogenous oestrogen on the haemostatic mechanismJ L Toy, J A Davies, K W Hancock, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestationA M Gillespie, E A Lidbury, J A Tidy, et al.
Journal of Endodontics|September 24, 2018
Antimicrobial Effect of Peptide DJK-5 Used Alone or Mixed with EDTA on Mono- and Multispecies Biofilms in Dentin CanalsDan Wang, Ya Shen, Robert E W Hancock, et al.
British Journal of Cancer|April 3, 1999
The presentation and management of post-partum choriocarcinomaL S Dobson, A M Gillespie, R E Coleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Cutting Edge: Multiple autoimmune pathways in kd/kd miceWayne W Hancock, Tsai-Lung Tsai, Michael P Madaio, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteinsJames T H Jo, Fiona S L Brinkman, Robert E W Hancock
British Journal of Cancer|May 2, 2000
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk diseaseL S Dobson, P C Lorigan, R E Coleman, et al.
Journal of Innate Immunity|April 21, 2012
Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellinAnastasia Nijnik, Jelena Pistolic, Niall C J Filewod, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 1, 2014
Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infectionsSarah C Mansour, César de la Fuente-Núñez, Robert E W Hancock
Clinical Cardiology|July 11, 2001
Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practiceA Eversole, W Hancock, T Johns, et al.
Pageof 117

Showing results (331-340 of 1,168) with videos related to

Sort By:
Pageof 117
Thrombosis and Haemostasis|June 30, 1978
The effects of an increase in endogenous oestrogen on the haemostatic mechanismJ L Toy, J A Davies, K W Hancock, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
The clinical presentation, treatment, and outcome of patients diagnosed with possible ectopic molar gestationA M Gillespie, E A Lidbury, J A Tidy, et al.
Journal of Endodontics|September 24, 2018
Antimicrobial Effect of Peptide DJK-5 Used Alone or Mixed with EDTA on Mono- and Multispecies Biofilms in Dentin CanalsDan Wang, Ya Shen, Robert E W Hancock, et al.
British Journal of Cancer|April 3, 1999
The presentation and management of post-partum choriocarcinomaL S Dobson, A M Gillespie, R E Coleman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 10, 2003
Cutting Edge: Multiple autoimmune pathways in kd/kd miceWayne W Hancock, Tsai-Lung Tsai, Michael P Madaio, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Aminoglycoside efflux in Pseudomonas aeruginosa: involvement of novel outer membrane proteinsJames T H Jo, Fiona S L Brinkman, Robert E W Hancock
British Journal of Cancer|May 2, 2000
Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk diseaseL S Dobson, P C Lorigan, R E Coleman, et al.
Journal of Innate Immunity|April 21, 2012
Signaling pathways mediating chemokine induction in keratinocytes by cathelicidin LL-37 and flagellinAnastasia Nijnik, Jelena Pistolic, Niall C J Filewod, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|November 1, 2014
Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infectionsSarah C Mansour, César de la Fuente-Núñez, Robert E W Hancock
Clinical Cardiology|July 11, 2001
Ibutilide: efficacy and safety in atrial fibrillation and atrial flutter in a general cardiology practiceA Eversole, W Hancock, T Johns, et al.
Pageof 117